Immunophenotyping of Circulating T Helper Cells Argues for Multiple Functions and Plasticity of T Cells In Vivo in Humans - Possible Role in Asthma

Background The immune process driving eosinophilic and non-eosinophilic asthma is likely driven by different subsets of T helper (Th) cells. Recently, in vitro studies and animal studies suggest that Th cell subsets displays plasticity by changing their transcription factor or by expressing multiple transcription factors. Our aim was to determine whether individuals with asthma and elevated circulating eosinophils express signs of different regulatory immune mechanisms compared with asthmatics with low blood eosinophils and non-asthmatic control subjects. In addition, determine the relationship between eosinophilia and circulating Th cell subsets. Methodology/Principal findings Participants were selected from a random epidemiological cohort, the West Sweden Asthma Study. Immunophenotypes of fresh peripheral blood cells obtained from stable asthmatics, with and without elevated eosinophilic inflammation (EOS high and EOS low respectively) and control subjects, were determined by flow cytometry. No differences in the number of Th1 (T-bet), Th2 (GATA-3), Th17 (RORγt) or Treg (FOXP3) cells were observed between the groups when analysing each subset separately. However, in all groups, each of the Th subsets showed expression of additional canonical transcription factors T-bet, GATA-3, RORγt and FOXP3. Furthermore, by in vitro stimulation with anti-CD3/anti-CD28 there was a significant increase of single expressing GATA-3+ and co-expressing T-bet+GATA-3+ cells in the EOS high asthmatics in comparison with control subjects. In addition, T-bet−GATA-3+RORγt+FOXP3+ were decreased in comparison to the EOS low asthmatics. Finally, in a group of control subjects we found that the majority of proliferating Th cells (CD4+CD25+Ki67+) expressed three or four transcription factors. Conclusions The ability of human Th cells to express several regulatory transcription factors suggests that these cells may display plasticity in vivo.

[1]  Keji Zhao,et al.  GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice. , 2011, The Journal of clinical investigation.

[2]  M. Rubio,et al.  Lung dendritic cells induce T(H)17 cells that produce T(H)2 cytokines, express GATA-3, and promote airway inflammation. , 2011, The Journal of allergy and clinical immunology.

[3]  Adnan Custovic,et al.  Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. , 2011, The Journal of allergy and clinical immunology.

[4]  Dave Singh,et al.  Increased airway T regulatory cells in asthmatic subjects. , 2010, Chest.

[5]  M. Akdiş.  The cellular orchestra in skin allergy; are differences to lung and nose relevant? , 2010, Current opinion in allergy and clinical immunology.

[6]  Christophe Benoist,et al.  Stability of the Regulatory T Cell Lineage in Vivo , 2010, Science.

[7]  Brigitta Stockinger,et al.  Effector T cell plasticity: flexibility in the face of changing circumstances , 2010, Nature Immunology.

[8]  W. Paul,et al.  Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells , 2010, Science.

[9]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[10]  Andreas Radbruch,et al.  Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. , 2010, Immunity.

[11]  D. Metzger,et al.  Emerging Roles of T Helper Subsets in the Pathogenesis of Asthma , 2010, Immunological investigations.

[12]  S. Jameson,et al.  Diversity in T cell memory: an embarrassment of riches. , 2009, Immunity.

[13]  H. Simon,et al.  Natural killer T cells expressing IFN‐γ and IL‐4 in lesional skin of atopic eczema , 2009, Allergy.

[14]  G. Wennergren,et al.  West Sweden Asthma Study: Prevalence trends over the last 18 years argues no recent increase in asthma , 2009, Respiratory research.

[15]  C. Bachert,et al.  Decreased FOXP3 protein expression in patients with asthma , 2009, Allergy.

[16]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[17]  R. Locksley.  Nine lives: plasticity among T helper cell subsets , 2009, The Journal of experimental medicine.

[18]  D. Littman,et al.  Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.

[19]  Daniel J. Campbell,et al.  T-bet controls regulatory T cell homeostasis and function during type-1 inflammation , 2009, Nature Immunology.

[20]  D. Littman,et al.  Identification of IL-17-producing FOXP3+ regulatory T cells in humans , 2009, Proceedings of the National Academy of Sciences.

[21]  Y. Nakanishi,et al.  Frequency of Foxp3+CD4+CD25+ T cells is associated with the phenotypes of allergic asthma , 2009, Respirology.

[22]  Mike Thomas,et al.  Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.

[23]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[24]  S. Wenzel.  Asthma: defining of the persistent adult phenotypes , 2006, The Lancet.

[25]  L. Glimcher,et al.  T cell directives for transcriptional regulation in asthma , 2004, Springer Seminars in Immunopathology.

[26]  X. Hua,et al.  Cell cycle controlling the silencing and functioning of mammalian activators , 2001, Current Biology.

[27]  J. Sedat,et al.  Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. , 2001, Immunity.

[28]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[29]  L. Cosmi,et al.  Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. , 2010, The Journal of allergy and clinical immunology.